Public

黑料正能量 Association content that is available to the public and all website users.

This week, Hacking Healthcare includes a breakdown the relevant elements of the European Union鈥檚 (EU) annual State of the Union speech, including cybersecurity, healthcare, and semi-conductors.
On September 21, 2021, VMware disclosed numerous vulnerabilities affecting their vCenter Server and Cloud Foundation products, some of which could be exploited for the deployment of ransomware or other malicious activity.
INTRODUCTION The FTC鈥檚 approach to defining the relevant geographic market in this case conflicts with settled law and economic principles, as well as business reality. In-deed, the FTC is attempting to do something that it has never directly attempted in hospital merger litigation鈥攄efine a鈥
The U.S. Department of the Treasury鈥檚 Office of Foreign Assets Control (OFAC) is issuing this updated advisory to highlight the sanctions risks associated with ransomware payments in connection with malicious cyber-enabled activities and the proactive steps companies can take to mitigate such鈥
A new analysis prepared by Kaufman, Hall & Associates, LLC and released today by the AHA shows that higher expenses for labor, drugs and supplies as well as patients putting off care during the ongoing COVID-19 pandemic will continue to negatively impact the financial health of hospitals and鈥
A new analysis prepared by Kaufman, Hall & Associates, LLC and released by the 黑料正能量 Association shows that higher expenses for labor, drugs and supplies as well as patients putting off care during the ongoing COVID-19 pandemic will continue to negatively impact the financial health鈥
As COVID-19 care demands 鈥渙utstrip resources鈥 at some Idaho hospitals, health care leaders came together to discuss how they are addressing the crisis and reiterate the solution: vaccination.
The Department of Health and Human Services鈥 (HHS) Assistant Secretary for Preparedness and Response (ASPR) Sept. 13 announced a major change in the distribution of COVID-19 monoclonal antibody therapies.